Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IL17A | Q16552 | 6/20 | 0.41 |
| ▸ | TRPA1 | O75762 | 4/20 | 0.32 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.31 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.31 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.30 |
| ▸ | TSHR | P16473 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30953029 | 0.89 | IL17A (0.38) | IL17AABCB11CHRM2SLCO1B1CYP3A4 | |
| SCHEMBL30953159 | 0.88 | IL17A (0.40) | IL17AMAPK1 | |
| SCHEMBL30952974 | 0.86 | IL17A (0.42) | IL17AABCB11CHRM2SLCO1B1MAPK1 | |
| SCHEMBL30952938 | 0.81 | IL17A (0.45) | IL17AABCB11CHRM2SLCO1B1 | |
| SCHEMBL30953013 | 0.81 | IL17A (0.46) | IL17AABCB11CHRM2SLCO1B1 | |
| SCHEMBL30953154 | 0.81 | CTSL (0.34) | — | |
| SCHEMBL30953030 | 0.81 | IL17A (0.47) | IL17AABCB11CHRM2SLCO1B1 | |
| SCHEMBL30953047 | 0.80 | IL17A (0.44) | IL17AABCB11CHRM2SLCO1B1 | |
| SCHEMBL30953257 | 0.80 | IL17A (0.40) | IL17AMAPK1 | |
| Hydrochloric Acid SCHEMBL30953455 | 0.79 | IL17A (0.43) | IL17AABCB11CHRM2SLCO1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4630115-A1 | THERAPEUTIC COMPOUNDS | Sanofi (FR) | 2025-10-15 | — | — | EP | claimed |
| WO-2024121427-A1 | THERAPEUTIC COMPOUNDS | SANOFI (FR) | 2024-06-13 | — | — | WO | claimed |
| EP-4630115-A1 | THERAPEUTIC COMPOUNDS | Sanofi (FR) | 2025-10-15 | — | — | EP | disclosed |
| WO-2024121427-A1 | THERAPEUTIC COMPOUNDS | SANOFI (FR) | 2024-06-13 | — | — | WO | disclosed |